| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.74B | 34.13B | 34.50B | 34.08B | 30.72B | 27.82B |
| Gross Profit | 6.03B | 6.10B | 5.89B | 6.31B | 6.40B | 5.75B |
| EBITDA | 3.01B | 2.86B | 3.49B | 3.69B | 4.04B | 3.46B |
| Net Income | 1.03B | 1.07B | 1.26B | 1.33B | 1.72B | 1.33B |
Balance Sheet | ||||||
| Total Assets | 72.65B | 72.34B | 73.61B | 70.63B | 69.23B | 65.24B |
| Cash, Cash Equivalents and Short-Term Investments | 14.32B | 12.42B | 12.66B | 12.59B | 15.35B | 14.34B |
| Total Debt | 3.28B | 3.26B | 4.14B | 5.76B | 5.86B | 5.70B |
| Total Liabilities | 17.11B | 16.96B | 18.27B | 19.01B | 19.57B | 17.14B |
| Stockholders Equity | 51.92B | 51.81B | 51.79B | 48.26B | 46.58B | 45.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 565.57M | 1.82B | -1.77B | 1.14B | 3.02B |
| Operating Cash Flow | 0.00 | 2.37B | 3.01B | -344.14M | 2.08B | 4.49B |
| Investing Cash Flow | 0.00 | -2.11B | -873.13M | -1.37B | -810.33M | -709.59M |
| Financing Cash Flow | 0.00 | -1.60B | -2.34B | -582.56M | -227.94M | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥162.86B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
77 Outperform | ¥21.89B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
76 Outperform | ¥256.03B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
72 Outperform | ¥17.95B | 7.65 | ― | 2.81% | -2.31% | -52.81% | |
72 Outperform | ¥235.48B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥111.43B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% |